Study: Biomarker may ID women at risk for gestational diabetes

08/13/2013 | ClinicalAdvisor.com

Glycosylated fibronectin rates higher than a threshold of 120 mg/L showed a 63% positive predictive value and accurately identified 57 of 90 pregnant women who developed gestational diabetes during their first trimester, according to a study in Obstetrics & Gynecology. Researchers said first-trimester glycosylated fibronectin may potentially serve as a biomarker to help identify women at risk of gestational diabetes.

View Full Article in:

ClinicalAdvisor.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN